Investor Information

At Century Pharmaceuticals Limited, we welcome the future with enthusiasm. Over the years, we have made a strong position to face the challenging future. Our company has a vision to get into new markets, establish advanced products, and build a brand across the world. We welcome Government financial institutions, NGOs, PE investors, Venture Capitalists, Pharmaceutical and Biotechnology companies to invest with us towards the development of a new, effective recombinant protein for the cure / treatment of Asthma & Allergies. Other indications are: Basophilic Leukemia and Mastocytosis. As we are able to develop this product successfully, we will give a new direction to marked therapeutics for other acute diseases like Leukemia, and find therapeutics for them!

Collaborations & Partnerships

MOU signed for the collaborative Research work, Sumandeep vidya peeth, Waghodia (Gujarat), for development of Recombinant fusion proteins that help treat Asthma & Allergy.

Also collaborated with Parul Institute of Pharmacy, Waghodia (Gujarat) for developing Therapeutic Defensin application, under industry academic partnerships.

MOU signed & collaborated with ICAR Institute of Fisheries Research, Mumbai, for developing Therapeutic Pholorotanin application, under Industry academic partnerships.

License & Technology Transfer

Authorized to develop as well as market worldwide, for projects on Recombinant proteins effective for the care of Asthma and Allergy, by Israeli Biotech Company Target-In.